Zoetis | ZTS - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
AbbVie USD 10.27B 1000K 2026-06
Align Technology USD 864.87M 2.84M 2026-06
Bayer EUR 10.04B 168M 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Charles River Laboratories USD 2.84B 1.96B 2026-06
Coherus Biosciences USD 51.83M 2.48M 2025-12
Dentsply International USD 1.35B 33M 2026-06
Eli Lilly USD 10.52B 496M 2026-06
Henry Schein USD 3.26B 84M 2026-06
Idexx Laboratories USD 791.02M 12.78M 2026-06
Illumina USD 899M 47M 2026-06
IQVIA Holdings USD 1.77B 4.45B 2026-06
J&J USD 17.83B 388M 2026-06
Laboratory Of America USD 3.27B 146.9M 2026-06
Merck USD 15.77B 2.4B 2026-06
Neogen USD 222.2M 7.7M 2026-03
Pacira USD 180.54M 7.79M 2026-06
Perrigo USD 290.5M 645.1M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Phibro Animal Health USD 361.83M 29.47M 2026-03
Quest Diagnostics USD 2.58B 88M 2026-06
Sanofi EUR 9.92B 607M 2026-06
Sanofi EUR 8.98B 1.73B 2026-03
Zoetis USD 3.15B 85M 2026-06